These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23320479)

  • 1. From intermittent antibiotic point prevalence surveys to quality improvement: experience in Scottish hospitals.
    Malcolm W; Nathwani D; Davey P; Cromwell T; Patton A; Reilly J; Cairns S; Bennie M
    Antimicrob Resist Infect Control; 2013 Jan; 2(1):3. PubMed ID: 23320479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009.
    Zarb P; Amadeo B; Muller A; Drapier N; Vankerckhoven V; Davey P; Goossens H;
    J Antimicrob Chemother; 2011 Feb; 66(2):443-9. PubMed ID: 21084362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme.
    Nathwani D; Sneddon J; Malcolm W; Wiuff C; Patton A; Hurding S; Eastaway A; Seaton RA; Watson E; Gillies E; Davey P; Bennie M;
    Int J Antimicrob Agents; 2011 Jul; 38(1):16-26. PubMed ID: 21515030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal point prevalence survey of antibacterial use in Northern Ireland using the European Surveillance of Antimicrobial Consumption (ESAC) PPS and Global-PPS tool.
    Al-Taani GM; Scott M; Farren D; Gilmore F; Mccullagh B; Hibberd C; Mccorry A; Versporten A; Goossens H; Zarb P; Aldeyab MA
    Epidemiol Infect; 2018 Jun; 146(8):985-990. PubMed ID: 29690946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe.
    Zarb P; Goossens H
    Drugs; 2011 Apr; 71(6):745-55. PubMed ID: 21504250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017.
    Vandael E; Latour K; Goossens H; Magerman K; Drapier N; Catry B; Versporten A;
    Antimicrob Resist Infect Control; 2020; 9(1):13. PubMed ID: 31956402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing a baseline for a national paediatric antimicrobial stewardship programme.
    Gibbons CL; Malcolm W; Sneddon J; Doherty C; Cairns S; Milne A; Llano M; Reilly JS
    J Antimicrob Chemother; 2019 Oct; 74(10):3104-3110. PubMed ID: 31299069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a multidisciplinary antimicrobial stewardship programme in a Philippine tertiary care hospital: an evaluation by repeated point prevalence surveys.
    de Guzman Betito G; Pauwels I; Versporten A; Goossens H; De Los Reyes MR; Gler MT
    J Glob Antimicrob Resist; 2021 Sep; 26():157-165. PubMed ID: 34118483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of acute-care antibiotic prescriptions for community-acquired infections and surgical antibiotic prophylaxis in England: analysis of 2016 national point prevalence survey data.
    Higgins H; Freeman R; Doble A; Hood G; Islam J; Gerver S; Henderson KL; Demirjian A; Hopkins S; Ashiru-Oredope D
    J Hosp Infect; 2023 Dec; 142():115-129. PubMed ID: 37858806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children.
    Versporten A; Bielicki J; Drapier N; Sharland M; Goossens H;
    J Antimicrob Chemother; 2016 Apr; 71(4):1106-17. PubMed ID: 26747104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial stewardship in Scotland: impact of a national programme.
    Nathwani D; Sneddon J; Patton A; Malcolm W
    Antimicrob Resist Infect Control; 2012 Feb; 1(1):7. PubMed ID: 22958296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK.
    Gharbi M; Doerholt K; Vergnano S; Bielicki JA; Paulus S; Menson E; Riordan A; Lyall H; Patel SV; Bernatoniene J; Versporten A; Heginbothom M; Goossens H; Sharland M;
    BMJ Open; 2016 Nov; 6(11):e012675. PubMed ID: 27810974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.
    Versporten A; Zarb P; Caniaux I; Gros MF; Drapier N; Miller M; Jarlier V; Nathwani D; Goossens H;
    Lancet Glob Health; 2018 Jun; 6(6):e619-e629. PubMed ID: 29681513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre point prevalence survey of patterns and quality of antibiotic prescribing in Indonesian hospitals.
    Limato R; Nelwan EJ; Mudia M; de Brabander J; Guterres H; Enty E; Mauleti IY; Mayasari M; Firmansyah I; Hizrani M; Hamers RL
    JAC Antimicrob Resist; 2021 Jun; 3(2):dlab047. PubMed ID: 33937773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the impact of the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) on hospital antimicrobial stewardship programmes: results of a worldwide survey.
    Pauwels I; Versporten A; Vermeulen H; Vlieghe E; Goossens H
    Antimicrob Resist Infect Control; 2021 Sep; 10(1):138. PubMed ID: 34583775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point Prevalence Survey of Antimicrobial Prescribing in a Nigerian Hospital: Findings and Implications on Antimicrobial Resistance.
    Fowotade A; Fasuyi T; Aigbovo O; Versporten A; Adekanmbi O; Akinyemi O; Goossens H; Kehinde A; Oduyebo O
    West Afr J Med; 2020; 37(3):216-220. PubMed ID: 32476113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing carbapenem use through a national quality improvement programme.
    Robson SE; Cockburn A; Sneddon J; Mohana A; Bennie M; Mullen AB; Malcolm W; Armstrong J; Patton A; Seaton RA
    J Antimicrob Chemother; 2018 Aug; 73(8):2223-2230. PubMed ID: 29800290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
    J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe.
    Coenen S; Ferech M; Haaijer-Ruskamp FM; Butler CC; Vander Stichele RH; Verheij TJ; Monnet DL; Little P; Goossens H;
    Qual Saf Health Care; 2007 Dec; 16(6):440-5. PubMed ID: 18055888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in antibiotic use across India: multi-centre study through Global Point Prevalence survey.
    Singh SK; Sengupta S; Antony R; Bhattacharya S; Mukhopadhyay C; Ramasubramanian V; Sharma A; Sahu S; Nirkhiwale S; Gupta S; Rohit A; Sharma S; Raghavan V; Barman P; Sood S; Mamtora D; Rengaswamy S; Arora A; Goossens H; Versporten A
    J Hosp Infect; 2019 Nov; 103(3):280-283. PubMed ID: 31170422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.